JUPITER, FL, UNITED STATES, February 25, 2026 /EINPresswire.com/ — Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage ...
Detailed price information for Jupiter Neurosciences Inc (JUNS-Q) from The Globe and Mail including charting and trades.
With our Phase IIa program underway and defined milestones in front of us, we look forward to engaging with investors and potential partners at BIO.” — Christer Rosén, Chairman and Chief Executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results